Brazil will receive supplies to produce Oxford's COVID-19 vaccines
Brasilia, Feb 27 (Prensa Latina) The Government of Brazil will receive on Saturday raw material to produce 12 million Covid-19 vaccines developed by the University of Oxford (United Kingdom) and the Anglo-Swedish company AstraZeneca in a national laboratory.
The so-called Active Pharmaceutical Ingredients (API) manufactured by the Wuxi Biologics laboratory, in China, will be stored at the Oswaldo Cruz Institute (Fiocruz), in Rio de Janeiro, the Ministries of Health and Foreign Relations reported.
This will be the second batch of APIs arriving in the country to produce the AstraZeneca vaccine. Brazil received from China the first batch of ingredient on January 6th.
The forecast is that the initial vaccines produced in the Institute will be delivered to the National Immunization Plan in the second half of March.
Fiocruz, the largest medical research center in Latin America that will produce and package the doses, confirmed the first delivery of the active ingredient.
The cargo had been ready since December, but was awaiting an export license and customs procedures so that the shipment could be sent.
The Government signed an agreement with Oxford / AstraZeneca for the production of the medicine at the Institute of Technology in Immunobiology (Bio-Manguinhos / Fiocruz).
|By the minute||Most read|